However, there have been no comprehensive and detailed meta-analysis studies of E-cadherin expression in malignant bone and soft tissue sarcomas that evaluate the impact of E-cadherin expression on the constitution of the architecture of these tumors or have determined the potential relationship between E-cadherin and overall survival. This evidence concerns the gene CDH1 and soft tissue sarcoma.